PBX1 and neoplasm: 21q gain occurred preferentially in hypodiploid tumours (Q = 0.10), whereas 9p loss was most frequent in TCF3-PBX1 translocated tumours (Q = 0.19), and (Supplementary Fig. 5a and 5b).